Lyon Street Capital’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-46,809
Closed -$1.02M 83
2020
Q2
$1.02M Buy
+46,809
New +$1.07M 2.05% 15
2020
Q1
Sell
-45,000
Closed -$1.49M 86
2019
Q4
$1.49M Buy
45,000
+6,692
+17% +$214K 2.53% 9
2019
Q3
$1.22M Sell
38,308
-6,692
-15% -$195K 2.25% 13
2019
Q2
$1.16M Buy
+45,000
New +$1.15M 1.97% 23
2018
Q2
Sell
-17,636
Closed -$593K 60
2018
Q1
$593K Sell
17,636
-326,009
-95% -$10.3M 0.19% 49
2017
Q4
$13.1M Buy
343,645
+50,748
+17% +$2.03M 4.38% 3
2017
Q3
$11M Buy
292,897
+62,107
+27% +$2.19M 4.23% 2
2017
Q2
$8.61M Sell
230,790
-524,377
-69% -$18.9M 3.46% 9
2017
Q1
$29.6M Buy
755,167
+299,151
+66% +$11.2M 11.88% 1
2016
Q4
$15.9M Buy
456,016
+142,936
+46% +$5.61M 8.11% 2
2016
Q3
$12.3M Buy
313,080
+74,294
+31% +$2.96M 6% 4
2016
Q2
$9.03M Buy
238,786
+66,017
+38% +$2.21M 5.09% 5
2016
Q1
$6.64M Buy
172,769
+31,200
+22% +$1.16M 3.75% 10
2015
Q4
$6.8M Sell
141,569
-33,499
-19% -$1.55M 4.53% 5
2015
Q3
$6.91M Buy
175,068
+30,909
+21% +$1.31M 5.01% 4
2015
Q2
$6.13M Sell
144,159
-75,534
-34% -$3.01M 4.41% 4
2015
Q1
$8.67M Sell
219,693
-8,282
-4% -$305K 3.73% 5
2014
Q4
$8.21M Buy
227,975
+28,326
+14% +$952K 3.41% 10
2014
Q3
$5.89M Buy
199,649
+69,584
+53% +$1.92M 2.76% 16
2014
Q2
$3.27M Buy
130,065
+82,033
+171% +$2.03M 1.44% 28
2014
Q1
$1.24M Buy
+48,032
New +$1.21M 0.57% 37

Other funds holding NTUS

Lyon Street Capital's NTUS Position: Q3 2020 in Review

Lyon Street Capital sold out of Natus Medical Inc (NTUS) in Q3 2020, closing a stake of 46,809 shares — an estimated $1.02M sold.

Lyon Street Capital first reported a position in NTUS in Q1 2014 and held it in 21 quarters. The position peaked at $29.6M in Q1 2017. 159 funds tracked by Wall St. Rank hold NTUS as of Q3 2020.

  • Lyon Street Capital reported no remaining Natus Medical Inc position as of Q3 2020 after selling out during the quarter.
  • Lyon Street Capital sold 46,809 Natus Medical Inc shares in Q3 2020, an estimated $1.02M.
  • Lyon Street Capital first reported a position in Natus Medical Inc in Q1 2014 and held it in 21 quarters.
  • Lyon Street Capital's Natus Medical Inc position peaked at $29.6M in Q1 2017.
  • 159 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2020.

Based on Lyon Street Capital's 13F filing for Q3 2020, filed 16 Nov 2020.